Clinical trial
ICON1: Physician Treatment Decisions and Patient-Reported Outcomes in Pediatric Refractory Immune Thrombocytopenia
NCT01971684 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ICON1: Physician Treatment Decisions and Patient-Reported Outcomes in Pediatric Refractory Immune Thrombocytopenia
- Lead sponsor
- Boston Children's Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- April 30, 2017
- Enrollment
- 120 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.
immune thrombocytopenia